Personalized Approach for Promoting Physical Activity in Mayo Clinic Physicians - Full Text View

Purpose

The purpose of the study is to determine if providing physicians with a walking workstation, exercise counseling, and accelerometer feedback about activity will increase physician activity.

Condition	Intervention
Weight Well Being	Device: GRUVE accelerometer (MUVE, inc.) Procedure: walking workstation Procedure: exercise counseling

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Personalized Approach for Promoting Physical Activity in Mayo Clinic Physicians

Resource links provided by NLM:

MedlinePlus related topics: Diabetes Medicines Exercise and Physical Fitness

U.S. FDA Resources

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:

Activity units determined by accelerometer [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

weight in kilograms [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
VO2 max [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Fitness as determined by an oxygen consumption treadmill test
% body fat determined by DEXA [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Fasting glucose [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Hemoglobin A1c [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Fasting insulin [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Fasting lipid profile [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
high sensitivity c-reactive protein [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Well Being using NCHS Well Being Scale [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Depression by CES-D Scale [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]
Linear Analog Self Assessment Scale [ Time Frame: 26 weeks ] [ Designated as safety issue: No ]

Enrollment:	17
Study Start Date:	July 2009
Study Completion Date:	November 2010
Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Walking workstation, counseling, accelerometry feedback 2 week baseline: accelerometer with no feedback 12 experimental: Use of the walking workstation, counseling on increasing activity levels, feedback from the accelerometer 12 week crossover: Feedback from accelerometer, no counseling or walking workstation	Device: GRUVE accelerometer (MUVE, inc.) Physicians in the experimental group will be given an activity monitoring device for 2 weeks (without feedback) prior to starting the study and will continue to have their activity monitored for the duration of the study. The device is an accelerometer (monitors movement and accurately estimates physical activity energy expenditure). They will receive feedback about their activity for the remainder of the trial. Physicians in the control group will wear the accelerometer but not receive feedback for the first 14 weeks of the trial. They will receive feedback for the last 12 weeks of the trial as they crossover to the experimental group. Procedure: walking workstation The physicians in the experimental group will be provided with a walking workstation. The walking workstation has a computer keyboard, computer monitor and telephone attached to an exercise treadmill (assembled by the investigators). This allows the user to walk at 1 MPH while dictating, typing, responding to e-mail, etc. The treadmill can be placed in an examining room if the physician wishes to use it while dictating notes or it can be placed in a separate office. For the last 12 weeks of the study the experimental group will not use the walking workstation while the control grop will use the workstation (crossover). Other Name: treadmill desk Procedure: exercise counseling After the first two weeks of baseline data collection, the experimental group will receive exercise counseling for the next 12 weeks. They will be advised to make use of the accelerometer device and the walking workstation as well as how to increase their activity in other ways. This group will not receive exercise counseling for the last 12 weeks of the study while the control group will cross over and receive exercise counseling for the last 12 weeks of the study (the control group will not receive exercise counseling for the first 14 weeks of the study).
Control then crossover 2 week baseline: accelerometer with no feedback 12 week control period: accelerometer with no feedback 12 week crossover period: accelerometer with feedback, counseling on increasing activity, and use of a walking workstation	Device: GRUVE accelerometer (MUVE, inc.) Physicians in the experimental group will be given an activity monitoring device for 2 weeks (without feedback) prior to starting the study and will continue to have their activity monitored for the duration of the study. The device is an accelerometer (monitors movement and accurately estimates physical activity energy expenditure). They will receive feedback about their activity for the remainder of the trial. Physicians in the control group will wear the accelerometer but not receive feedback for the first 14 weeks of the trial. They will receive feedback for the last 12 weeks of the trial as they crossover to the experimental group. Procedure: walking workstation The physicians in the experimental group will be provided with a walking workstation. The walking workstation has a computer keyboard, computer monitor and telephone attached to an exercise treadmill (assembled by the investigators). This allows the user to walk at 1 MPH while dictating, typing, responding to e-mail, etc. The treadmill can be placed in an examining room if the physician wishes to use it while dictating notes or it can be placed in a separate office. For the last 12 weeks of the study the experimental group will not use the walking workstation while the control grop will use the workstation (crossover). Other Name: treadmill desk Procedure: exercise counseling After the first two weeks of baseline data collection, the experimental group will receive exercise counseling for the next 12 weeks. They will be advised to make use of the accelerometer device and the walking workstation as well as how to increase their activity in other ways. This group will not receive exercise counseling for the last 12 weeks of the study while the control group will cross over and receive exercise counseling for the last 12 weeks of the study (the control group will not receive exercise counseling for the first 14 weeks of the study).

Arms

Assigned Interventions

Experimental: Walking workstation, counseling, accelerometry feedback

2 week baseline: accelerometer with no feedback 12 experimental: Use of the walking workstation, counseling on increasing activity levels, feedback from the accelerometer 12 week crossover: Feedback from accelerometer, no counseling or walking workstation

Device: GRUVE accelerometer (MUVE, inc.)

Physicians in the experimental group will be given an activity monitoring device for 2 weeks (without feedback) prior to starting the study and will continue to have their activity monitored for the duration of the study. The device is an accelerometer (monitors movement and accurately estimates physical activity energy expenditure). They will receive feedback about their activity for the remainder of the trial. Physicians in the control group will wear the accelerometer but not receive feedback for the first 14 weeks of the trial. They will receive feedback for the last 12 weeks of the trial as they crossover to the experimental group.

Procedure: walking workstation

The physicians in the experimental group will be provided with a walking workstation. The walking workstation has a computer keyboard, computer monitor and telephone attached to an exercise treadmill (assembled by the investigators). This allows the user to walk at 1 MPH while dictating, typing, responding to e-mail, etc. The treadmill can be placed in an examining room if the physician wishes to use it while dictating notes or it can be placed in a separate office. For the last 12 weeks of the study the experimental group will not use the walking workstation while the control grop will use the workstation (crossover).

Other Name: treadmill desk

Procedure: exercise counseling

After the first two weeks of baseline data collection, the experimental group will receive exercise counseling for the next 12 weeks. They will be advised to make use of the accelerometer device and the walking workstation as well as how to increase their activity in other ways. This group will not receive exercise counseling for the last 12 weeks of the study while the control group will cross over and receive exercise counseling for the last 12 weeks of the study (the control group will not receive exercise counseling for the first 14 weeks of the study).

Control then crossover

2 week baseline: accelerometer with no feedback 12 week control period: accelerometer with no feedback 12 week crossover period: accelerometer with feedback, counseling on increasing activity, and use of a walking workstation

Device: GRUVE accelerometer (MUVE, inc.)

Physicians in the experimental group will be given an activity monitoring device for 2 weeks (without feedback) prior to starting the study and will continue to have their activity monitored for the duration of the study. The device is an accelerometer (monitors movement and accurately estimates physical activity energy expenditure). They will receive feedback about their activity for the remainder of the trial. Physicians in the control group will wear the accelerometer but not receive feedback for the first 14 weeks of the trial. They will receive feedback for the last 12 weeks of the trial as they crossover to the experimental group.

Procedure: walking workstation

The physicians in the experimental group will be provided with a walking workstation. The walking workstation has a computer keyboard, computer monitor and telephone attached to an exercise treadmill (assembled by the investigators). This allows the user to walk at 1 MPH while dictating, typing, responding to e-mail, etc. The treadmill can be placed in an examining room if the physician wishes to use it while dictating notes or it can be placed in a separate office. For the last 12 weeks of the study the experimental group will not use the walking workstation while the control grop will use the workstation (crossover).

Other Name: treadmill desk

Procedure: exercise counseling

After the first two weeks of baseline data collection, the experimental group will receive exercise counseling for the next 12 weeks. They will be advised to make use of the accelerometer device and the walking workstation as well as how to increase their activity in other ways. This group will not receive exercise counseling for the last 12 weeks of the study while the control group will cross over and receive exercise counseling for the last 12 weeks of the study (the control group will not receive exercise counseling for the first 14 weeks of the study).

Detailed Description:

20 physicians will be given an activity monitoring device (GRUVE from MUVE, inc.) for 2 weeks prior to starting the study (without feedback) and will continue to have their activity monitored for the duration of the study. The device is an accelerometer (monitors movement and accurately estimates physical activity energy expenditure). The physicians will be randomized to 12 weeks with accelerometer monitoring but no feedback or counseling (control) or to 12 weeks of accelerometer monitoring (experimental) with feedback about activity levels and 20 minute weekly counseling sessions on how to increase activity (including walking while working). In the 12 week period where physicians receive feedback and counseling, they will also be provided a walking workstation. The walking workstation (assembled by the investigators) has a computer keyboard, computer monitor and telephone attached to an exercise treadmill. This allows the user to walk at 1 MPH while dictating, typing, responding to e-mail, etc. The treadmill can be placed in an examining room if the physician wishes to use it while dictating notes or it can be placed in a separate office.

Those physicians assigned to monitoring only for the first 12 weeks will then receive monitoring plus feedback, counseling, and walking workstation use for the next 12 weeks. Those physicians assigned to feedback, counseling, and walking workstation use for the first 12 weeks will continue to receive accelerometer feedback but will no longer receive counseling or use a walking workstation for the subsequent 12 weeks.

Ten physicians will complete the above for the first 26 weeks of the study and 10 physicians will complete the above for the last 26 weeks of the study.

The time line of the study is as follows:

12 Wks Experimental → 12 Wks Control 10 MDs (Wk 1-26) → 2 wks Monitor 12 Wks control → 12 Wks Experimental

12 Wks Experimental → 12 Wks Control 10 MDs (Wk 27-52) → 2 wks Monitor 12 Wks control → 12 Wks Experimental

In summary, physicians use an accelerometer without feedback while in the control group. In the experimental group physicians receive three interventions: accelerometer with feedback, exercise counseling, and the use of a walking workstation (treadmill desk).

Eligibility

Ages Eligible for Study:	25 Years to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Physicians working in the Department of Medicine at Mayo Clinic Rochester
Age 25 to 70 years
BMI > 25
Sedentary (exercise for 30 minutes less than 3 times weekly)

Exclusion Criteria:

Metastatic cancer
Unable to complete a Bruce protocol exercise stress test
Planning on retiring in the next 6 months
Planning on more than 3 weeks of vacation during the 6 month study
Women of child-bearing age who are pregnant or planning on becoming pregnant.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01501994

Sponsors and Collaborators

Mayo Clinic

Investigators

Principal Investigator:

Warren G Thompson, MD

Mayo Clinic

More Information

No publications provided

Responsible Party:	Warren G. Thompson, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:	NCT01501994 History of Changes
Other Study ID Numbers:	07-007103
Study First Received:	November 29, 2011
Last Updated:	August 21, 2012
Health Authority:	United States: Institutional Review Board

Keywords provided by Mayo Clinic:

Activity level
Weight
Body Fat
Well Being

ClinicalTrials.gov processed this record on May 23, 2013